In Ukraine, 90 percent of the total spending on pharmaceuticals was paid privately in 2018. That was the highest share among presented countries in Eastern Europe and Central Asia. To compare, the private expenditure share in Tajikistan was measured at 63 percent.
Share of total pharmaceutical expenditure paid privately in Eastern Europe and Central Asia in 2018, by selected country
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Country comparison in spending on medicine 2026
- Basic Statistic Worldwide top drug producing mechanisms of action by number of active compounds 2024
- Premium Statistic Number of drugs in the R&D pipeline worldwide 2001-2024
- Basic Statistic Drugs in R&D pipeline worldwide 2023-2024, by phase of development
- Premium Statistic Top pharma companies worldwide 2024, by size of R&D pipeline
- Premium Statistic Drug production value share of hormones Japan 2021, by category
- Premium Statistic Drug production value of traditional Chinese medicines Japan 2013-2022
- Premium Statistic Drug production value of cardiovascular agents Japan 2022, by category
- Premium Statistic Drug production value share of antibiotics Japan 2016, by category
- Premium Statistic Pharmaceutical market size in China 2016-2022
About the region
10
- Premium Statistic Number of hospital beds in Kuwait 2010-2021
- Premium Statistic Density rate of physicians in the GCC 2011-2020
- Premium Statistic Number of hospital beds in the UAE 2010-2021
- Premium Statistic Number of hospital beds in Qatar 2010-2017
- Basic Statistic Most important export partners of the Kyrgyz Republic in 2019
- Premium Statistic Number of eHR Registration Centers Hong Kong by region 2022
- Premium Statistic Total health expenditure as share of GDP SEA 2020, by country
- Premium Statistic Total health expenditure per capita SEA 2020, by country
- Premium Statistic Gross medical cost trend APAC 2020-2022, by country or region
- Premium Statistic Net medical cost trend APAC 2020-2022, by country or region
Selected statistics
8
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
- Basic Statistic Merck & Co total assets 2009-2023
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
Other regions
10
- Basic Statistic Pharmaceutical spending per capita in selected countries 2022
- Basic Statistic Social distance to Central Asian ethnicities in Russia 2021
- Premium Statistic Expenditure for oncology drugs in Italy 2022, by category
- Premium Statistic Value of FDI in the healthcare market India 2000-2023, by sector
- Basic Statistic Milliman medical index in U.S. 2013-2023
- Basic Statistic Spending on health per capita South Korea 2012-2022
- Basic Statistic Average medicine costs and tariff revenues per pharmacy in the Netherlands 2011-2022
- Basic Statistic Number of deaths caused by drug poisoning in the UK 2021, by gender and age
- Premium Statistic Biologic share of total pharmaceutical sales in select countries 2018
- Basic Statistic Usage of infliximab biosimilars in select countries 2018
Related statistics
10
- Basic Statistic Social distance of Russians to other ethnicities 2021, by group
- Basic Statistic Mortality rate from cancer in Russia 2022, by federal subject
- Premium Statistic Motivating factors to choose private healthcare in Moscow 2022
- Premium Statistic Salary of medical professionals in public sector in Russia 2022, by level & region
- Premium Statistic Number of public sector medical professionals in Russia 2018-2022, by level
- Premium Statistic Most popular medications in Russia 2023, by sales value
- Basic Statistic Number of epidemiologists in Russia 1990-2021
- Basic Statistic Number of infectious diseases beds in Russia 1990-2022
- Premium Statistic Structure of expenditure on healthcare in Russia 2019-2024, by source
- Basic Statistic Average spend in pharmacies in Russia Q1 2021, by region
Further related statistics
10
- Top 10 most expensive conditions treated in the U.S. - hospitals stays 2017
- Expenditure worldwide on diabetes by market 2013-2018
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Total assets of UnitedHealth Group 2007-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Walgreens operating income in the U.S. 2005-2023
- New cases of Lyme disease in the U.S. 1991-2019
Further Content: You might find this interesting as well
Statistics
- Top 10 most expensive conditions treated in the U.S. - hospitals stays 2017
- Expenditure worldwide on diabetes by market 2013-2018
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Total assets of UnitedHealth Group 2007-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Walgreens operating income in the U.S. 2005-2023
- New cases of Lyme disease in the U.S. 1991-2019
WHO. (September 2, 2020). Share of total pharmaceutical expenditure paid privately in Eastern Europe and Central Asia in 2018, by selected country [Graph]. In Statista. Retrieved May 23, 2024, from https://www.statista.com/statistics/1169580/pharma-private-spending-share-eastern-europe-and-central-asia-by-country/
WHO. "Share of total pharmaceutical expenditure paid privately in Eastern Europe and Central Asia in 2018, by selected country." Chart. September 2, 2020. Statista. Accessed May 23, 2024. https://www.statista.com/statistics/1169580/pharma-private-spending-share-eastern-europe-and-central-asia-by-country/
WHO. (2020). Share of total pharmaceutical expenditure paid privately in Eastern Europe and Central Asia in 2018, by selected country. Statista. Statista Inc.. Accessed: May 23, 2024. https://www.statista.com/statistics/1169580/pharma-private-spending-share-eastern-europe-and-central-asia-by-country/
WHO. "Share of Total Pharmaceutical Expenditure Paid Privately in Eastern Europe and Central Asia in 2018, by Selected Country." Statista, Statista Inc., 2 Sep 2020, https://www.statista.com/statistics/1169580/pharma-private-spending-share-eastern-europe-and-central-asia-by-country/
WHO, Share of total pharmaceutical expenditure paid privately in Eastern Europe and Central Asia in 2018, by selected country Statista, https://www.statista.com/statistics/1169580/pharma-private-spending-share-eastern-europe-and-central-asia-by-country/ (last visited May 23, 2024)
Share of total pharmaceutical expenditure paid privately in Eastern Europe and Central Asia in 2018, by selected country [Graph], WHO, September 2, 2020. [Online]. Available: https://www.statista.com/statistics/1169580/pharma-private-spending-share-eastern-europe-and-central-asia-by-country/